Modern approach to the evaluation of the pharmacokinetics and pharmacodynamics of biosimilar recombinant human insulin and insulin analogues in I phase clinical study

Modern approach to the evaluation of the pharmacokinetics and pharmacodynamics of biosimilar recombinant human insulin and insulin analogues in I phase clinical study

The quality, pharmacokinetic and pharmacodynamic profiles, safety and immunogenicity must be compared to demonstrate the bio-similarities of recombinant human insulin and insulin analogues. To confirm these bio-similarities in clinical studies, it is necessary to adhere to a multi-phased approach, s...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak:	Irina A. Proskurina, Alexander Y. Mayorov, Dmitriy V. Gorachev, Natalya D. Bunyatyan
Formatua:	Artikulua
Hizkuntza:	English
Argitaratua:	Endocrinology Research Centre 2016-07-01
Saila:	Сахарный диабет
Gaiak:	biosimilar recombinant human insulin insulin analogues euglycaemic hyperinsulinaemic clamp-study
Sarrera elektronikoa:	https://www.dia-endojournals.ru/jour/article/view/7793

Antzeko izenburuak

Whole body insulin responsiveness is higher in beef steers selected for increased muscling
nork: P. McGilchrist, et al.
Argitaratua: (2011-01-01)

The Effect of Regular Exercise on Insulin Sensitivity in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
nork: Kimberley L. Way, et al.
Argitaratua: (2016-08-01)

Pharmacokinetic and pharmacodynamic similarity evaluation between an insulin glargine biosimilar product and Lantus® in healthy subjects: Pharmacokinetic parameters of both parent insulin glargine and M1 were used as endpoints
nork: Yiya Wang, et al.
Argitaratua: (2022-08-01)

Study of equivalence and comparable immunogenicity of biosimilar insulin aspart in comparison with the registered analogue
nork: Т. L. Karonova, et al.
Argitaratua: (2022-06-01)

After 100 years of life, is there an insulin crisis? The problem of insulin costs and the opportunity of biosimilar insulins
nork: Domenico Cucinotta, et al.
Argitaratua: (2023-02-01)

Closing anion gap without insulin in euglycaemic diabetic ketoacidosis
nork: Resham Raj Poudel, et al.
Argitaratua: (2017-01-01)

Biosimilar insulins in international and domestic practice of pharmacist
nork: I. O. Vlasenko, et al.
Argitaratua: (2022-02-01)

Does all the evidence say that insulin analogues are more effective than human insulins?
nork: M.V. Neborachko, et al.
Argitaratua: (2021-11-01)

Insulin biosimilars in clinical practice
nork: A. F. Verbovoy, et al.
Argitaratua: (2022-01-01)

Factors influencing bioequivalence evaluation of insulin biosimilars based on a structural equation model
nork: Huarui Shao, et al.
Argitaratua: (2023-04-01)

A practical guide to the interpretation of PK/PD profiles of longer-acting analogue insulins. Part two: Insulin degludec vs. insulin glargine U300
nork: Oppel B.W. Greeff, et al.
Argitaratua: (2018-08-01)

Downstream processing of recombinant human insulin and its analogues production from E. coli inclusion bodies
nork: Yin Yin Siew, et al.
Argitaratua: (2021-07-01)

Results of the Estimation of Biosimilarity of RinLiz<sup>®</sup> (LLC «GEROPHARM», Russia) and Humalog<sup>®</sup> (Lilly France, France) Using the Method of the Hyperinsulinemic Eulygemic Clamp on Healthy Voluntary
nork: A. Yu. Mayorov, et al.
Argitaratua: (2020-05-01)

Results of a double-blind, randomized, comparative, cross-sectional study of the pharmacokinetics and pharmacodynamics of genetically engineered human insulin preparations
nork: Alexander Mayorov, et al.
Argitaratua: (2019-09-01)

Biosimilar of biphasic human insulin: results of a double-blind, randomized, comparative, cross-sectional clinical study of pharmacokinetics
nork: Tatyana Karonova, et al.
Argitaratua: (2019-09-01)

Modern Approaches to Determination of the Biological Activity of Insulin and Its Analogues
nork: T. A. Batuashvili, et al.
Argitaratua: (2019-06-01)

Treatment of Type 2 Diabetes with Biphasic Insulin Analogues
nork: Ali A. Rizvi
Argitaratua: (2016-10-01)

Biosimilar insulins – What a clinician needs to know?
nork: Sujoy Ghosh, et al.
Argitaratua: (2019-01-01)

Immunogenicity and Efficacy of Insulin Glargine Biosimilar Ezelin versus Originator Insulin Glargine in Patients with Type 2 Diabetes
nork: Tarigan TJE, et al.
Argitaratua: (2021-01-01)

Insulin analogues and cancer: a note of caution
nork: Joseph A.M.J.L. eJanssen, et al.
Argitaratua: (2014-05-01)

Life threatening hypokalaemia during treatment of severe diltiazem overdose with high dose insulin euglycemic therapy: a case report
nork: Andrew Kozman, et al.
Argitaratua: (2021-11-01)

Case report: Glycaemic management and pregnancy outcomes in a woman with an insulin receptor mutation, p.Met1180Lys
nork: Mairéad T. Crowley, et al.
Argitaratua: (2024-03-01)

Insulin-induced Lipoatrophy in a Patient on Insulin Analogue Therapy: a Case Report
nork: Vesselina Yanachkova, et al.
Argitaratua: (2020-09-01)

Enzyme-Linked Immunosorbent Assay Method Application in the Study of Comparative Pharmacokinetics of Insulin Glargin Preparations
nork: L. N. Shitov, et al.
Argitaratua: (2019-04-01)

Comparative Study between the Glycemic Control of Human Insulin and Insulin analogue In Sample of Iraqi Type 1 Diabetic Children and Adolescents
nork: Noor Wafaa Hashim, et al.
Argitaratua: (2018-12-01)

Chromatographic and massspectrometric analysis of glycosylated recombinant human insulin.
nork: M. N. Korchaznikova, et al.
Argitaratua: (2009-10-01)

Health Technology Assessment on Insulin Analogues: the Rapid Review of Second Type Studies
nork: A Oliyaeemanesh, et al.
Argitaratua: (2012-07-01)

Degludec insulin: A novel basal insulin
nork: Sanjay Kalra, et al.
Argitaratua: (2011-01-01)

Assessment the equivalence of the bioanalogue insulin lizpro biphasic 25 (Geropharm-bio, Russia) and Humalog® Mix 25 (Lilly France, France) using the euglycemic hyperinsulinum clamp method on healthy volonters
nork: Alexander Y. Mayorov, et al.
Argitaratua: (2018-12-01)

Insulin degludec: a new basal insulin analogue with an ultra-long duration of action. Safety and efficacy in Russian patients with diabetes
nork: Marina Vladimirovna Shestakova, et al.
Argitaratua: (2015-12-01)

Study of polysialated recombinant human insulin
nork: M. N. Korchagnikova, et al.
Argitaratua: (2009-04-01)

How to Achieve Sufficient Endogenous Insulin Suppression in Euglycemic Clamps Assessing the Pharmacokinetics and Pharmacodynamics of Long-Acting Insulin Preparations Employing Healthy Volunteers
nork: Hui Liu, et al.
Argitaratua: (2022-07-01)

Biosimilars: presumption of guilt
nork: Marina Vladimirovna Shestakova, et al.
Argitaratua: (2011-12-01)

A practical guide to the interpretation of PK/PD profiles of longer-acting analogue insulins. Part one: The principles of glucose clamp studies
nork: Oppel B.W. Greeff, et al.
Argitaratua: (2018-07-01)

Efficacy and immunogenicity of insulin biosimilar compared to their reference products: a systematic review and meta-analysis
nork: Li-Jou Yang, et al.
Argitaratua: (2022-02-01)

Biosimilars: A novel perspective in diabetes therapy
nork: Muthu Thiruvengadam, et al.
Argitaratua: (2020-01-01)

Effect of human insulin and insulin analogue on some inflammatory markers and total antioxidant capacity in a sample of Iraqi type 1 diabetic children and adolescents
nork: Noor Wafaa Hashim, et al.
Argitaratua: (2022-04-01)

Individual stepwise intensification of insulin analogue therapy in type 2 diabetes mellitus
nork: Alexander Sergeevich Ametov, et al.
Argitaratua: (2012-12-01)

Modern approach to basal-bolus therapy with glargine and glulisine insulin analoguesin various age groups
nork: Natalya Nikitichna Volevodz, et al.
Argitaratua: (2013-03-01)

On the centenary of the insulin discovery
nork: I. I. Dedov, et al.
Argitaratua: (2021-02-01)